Why Is This Cannabis Company Up 15% Today?

Posted On February 27, 2019 2:56 pm
By: Steve Smith

GW Pharma (GWPH) is a medical marijuana company that is truly about “getting well, not getting high” and may end up being the best long term investment in the entire cannabis sector.

Most of the buzz (pun intended) surrounding the cannabis industry pertains to using the THC component for recreational purposes of getting high.

There’s also the area of using Cannabidiol (CBD), which is non-intoxicating, in various forms for moderately-therapeutic uses such as pain management, relief of anxiety and nausea other non-life threatening ailments.

A lot of speculative money has been thrown into these areas and will be due for a shakeout with just a few winners and many losers.

And then there are applications that are truly medical. This refers to pharmaceutical applications for developing drugs to treat serious diseases or chronic conditions, ranging from epilepsy to cancer. This area that could have the greatest impact on disrupting the healthcare industry and result in several multi-billion dollar prescription drugs.

My top pick is…

Continue reading at StockNews.com

Tagged with: marijuana stocks

About author

Steve Smith

Steve Smith have been involved in all facets of the investment industry in a variety of roles ranging from speculator, educator, manager and advisor. This has taken him from the trading floors of Chicago to hedge funds on Wall Street to the world online. From 1987 to 1996, he served as a market maker at the Chicago Board of Options Exchange (CBOE) and Chicago Board of Trade (CBOT). From 1997 to 2007, he was a Senior Columnist and Managing Editor for TheStreet.com, handling their Option Alert and Short Report newsletters. The Option Alert was awarded the MIN “best business newsletter” in 2006. From 2009 to 2013, Smith was a Senior Columnist and Managing Editor for Minyanville’s OptionSmith newsletter, as well as a Risk Manager Consultant for New Vernon Capital LLC. Smith acted as an advisor to build models and option strategies to reduce portfolio exposure and enhance returns for the four main funds. Since 2015, he has worked for Adam Mesh Trading Group. There, he has managed Options360 and Earning 360, been co-leader of Option Academy, and contributed to The Option Specialist website.